Table of contents

Liver

• Severe hepatic injury in interleukin 18 (IL-18) transgenic mice: a key role for IL-18 in regulating hepatocyte apoptosis in vivo (11 February, 2004)

  S Finotto, J Siebler, M Hausding, M Schipp, S Wirtz, S Klein, M Protschka, A Doganci, H A Lehr, C Trautwein, R Khosravi-Fahr, D Strand, A Lohse, P R Galle, M Blessing, M F Neurath
• Improved characterisation of histologically proven liver tumours by contrast enhanced ultrasonography during the portal venous and specific late phase of SHU 508A (11 February, 2004)

  C F Dietrich, A Ignee, J Trojan, C Fellbaum, G Schuessler
• Steatosis affects chronic hepatitis C progression in a genotype specific way (11 February, 2004)

  L Rubbia-Brandt, P Fabris, S Paganin, G Leandro, P-J Male, E Giostra, A Carlotto, L Bozzola, A Smedile, F Negro
• Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life (11 February, 2004)

  I J Hickman, J R Jonsson, J B Prins, S Ash, D M Purdie, A D Clouston, E E Powell
• Effect of antiviral treatment on evolution of liver steatosis in patients with chronic hepatitis C: indirect evidence of a role of hepatitis C virus genotype 3 in steatosis (11 February, 2004)

  L Castéra, C Hézode, F Roudot-Thoraval, I Lonjon, E-S Zafrani, J-M Pawlotsky, D Dhumeaux
• Benefit of interferon therapy in hepatocellular carcinoma prevention for individual patients with chronic hepatitis C (11 February, 2004)

  H Yoshida, R Tateishi, Y Arakawa, M Sata, S Fujiyama, S Nishiguchi, H Ishibashi, G Yamada, O Yokosuka, Y Shiratori, M Omata
• Randomised controlled trial of long term portographic follow up versus variceal band ligation following transjugular intrahepatic portosystemic stent shunt for preventing oesophageal variceal rebleeding (11 February, 2004)

  D Tripathi, H F Lui, A Helmy, K Dabos, E Forrest, A J Stanley, R Jalan, D N Redhead, P C Hayes